Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (41-50 of 279) with videos related to

Pageof 28
Sort By:
Annals of Neurology|February 27, 2010
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal agingJohn C Morris, Catherine M Roe, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief ReportGanesh M Babulal, Sarah H Stout, Denise Head, et al.
JAMA Neurology|August 23, 2016
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease PathophysiologyBrian A Gordon, Tyler Blazey, Yi Su, et al.
JAMA Neurology|April 14, 2015
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer DiseaseRawan Tarawneh, Denise Head, Samantha Allison, et al.
Alzheimer Disease and Associated Disorders|December 14, 2011
Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer typeLei Wang, Anne M Fagan, Aarti R Shah, et al.
Neurogenetics|September 25, 2008
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid betaJohn S K Kauwe, Jun Wang, Kevin Mayo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET statusJune Kaplow, Manu Vandijck, Julia Gray, et al.
Alzheimer Disease and Associated Disorders|November 30, 2018
Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer DiseaseKavon Javaherian, Brianne M Newman, Hua Weng, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's DiseaseAndrew J Aschenbrenner, Brian A Gordon, Anne M Fagan, et al.
Journal of Alzheimer'S Disease : JAD|October 30, 2016
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's DiseasePiotr Lewczuk, Anja Matzen, Kaj Blennow, et al.
Pageof 28

Showing results (41-50 of 279) with videos related to

Sort By:
Pageof 28
Annals of Neurology|February 27, 2010
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal agingJohn C Morris, Catherine M Roe, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief ReportGanesh M Babulal, Sarah H Stout, Denise Head, et al.
JAMA Neurology|August 23, 2016
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease PathophysiologyBrian A Gordon, Tyler Blazey, Yi Su, et al.
JAMA Neurology|April 14, 2015
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer DiseaseRawan Tarawneh, Denise Head, Samantha Allison, et al.
Alzheimer Disease and Associated Disorders|December 14, 2011
Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer typeLei Wang, Anne M Fagan, Aarti R Shah, et al.
Neurogenetics|September 25, 2008
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid betaJohn S K Kauwe, Jun Wang, Kevin Mayo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET statusJune Kaplow, Manu Vandijck, Julia Gray, et al.
Alzheimer Disease and Associated Disorders|November 30, 2018
Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer DiseaseKavon Javaherian, Brianne M Newman, Hua Weng, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's DiseaseAndrew J Aschenbrenner, Brian A Gordon, Anne M Fagan, et al.
Journal of Alzheimer'S Disease : JAD|October 30, 2016
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's DiseasePiotr Lewczuk, Anja Matzen, Kaj Blennow, et al.
Pageof 28